BlessingBox Profile picture
Technical writer w/ specialization in social media, RN/CRRN, cultural creative, fact hacker, progressive, political junkie, pain advocate, hopeless dog lover!
Dec 23, 2023 14 tweets 5 min read
Backstory on everything you did or didn’t want to know about FDA Overdose Prevention Framework Including FDA approval of #AvertD
Circa 2022-2023 ⤵️

Public Citizen weighs in on FDA approval AvertD with Kolodny’s collaboration essentially stating that AvertD is null & void because all opioids are addictive- regardless.

Image
May 1, 2023 4 tweets 2 min read
AI Accountability Policy Request for Comment
Federal Register
Agency/Docket No. 230407-0093
Comments Close:
06/12/2023

federalregister.gov/documents/2023… The RFC seeks comment on artificial intelligence (AI) system accountability measures and policies.

jdsupra.com/legalnews/ntia… Image
Oct 20, 2022 19 tweets 8 min read
FDA's Clinical Chemistry and Clinical Toxicology Devices Advisory Committee will meet to discuss *AvertD, a prescription genetic risk assessment tool for opioid use disorder (OUD).”



FDA briefing documents ahead of the meeting.


fda.gov/media/162373/d…
FDA advisory committee on Thursday voted strongly against AvertD, a prescription genetic risk assessment tool for opioid use disorder (OUD).

medpagetoday.com/painmanagement…
Image
Oct 16, 2022 21 tweets 10 min read
You can’t build public health policy upon 🍒 picked studies & call it “evidenced based, or best practices” by fudging data.
You can however, call it conflict of interest, agenda, propaganda, undermining of research/practice of medicine w/ outcomes directly impact patient’s lives. Image It’s pertinent to demand disclosure regarding the content/ findings of omitted “unpublished studies,” why were they not published, who made those decisions & how many other agencies & what other studies under @OIGatHHS oversight have ongoing non-compliance?
See article 4 link ⬆️ ImageImageImage
Apr 13, 2021 15 tweets 8 min read
“Integrative Medicine Research Lecture/National Center Complementary & Integrative Health/ Univ Utah dev/ testing integrative nondrug treatment strategy, Mindfulness-Oriented Recovery Enhancement (MORE)➡️ bio-psychosocial NIH research
#NATIONALPAINSTRATEGY
nccih.nih.gov/news/events/he… Integrative Medicine Research/ National Center Complementary/ Integrative Health/ Dr. Alicia Heapy/ Yale/ VA ➡️ non-drug intervention for pain—Cooperative Pain Education Self-Management (COPES), a form of cognitive behavioral therapy.
#NATIONALPAINSTRATEGY
nccih.nih.gov/news/events/co…
Dec 14, 2020 5 tweets 2 min read
“The American Medical Association is once again urging states, regulators and policymakers to waive limits and restrictions on prescriptions for opioid medication and other controlled substances during the COVID-19 pandemic.” PNN Issue brief: Reports of increases in opioid- and other drug-related overdose and other concerns during COVID pandemic
*Updated December 9, 2020

ama-assn.org/system/files/2…
Dec 11, 2020 5 tweets 2 min read
The DEA published this notice of proposed rule on December 4, 2020 and there is a 60-day comment period thereafter.  Partial Filling of Prescriptions for Schedule II Controlled Substances, 85 Fed. Reg. 78,282 (proposed Dec. 4, 2020). DEPARTMENT OF JUSTICE
Drug Enforcement Administration
21 CFR Part 1306 [Docket No. DEA–469] RIN 1117–AB45
Partial Filling of Prescriptions for Schedule II Controlled Substances
AGENCY: Drug Enforcement Administration, Department of Justice. govinfo.gov/content/pkg/FR…
Dec 11, 2020 6 tweets 5 min read
Full and complete 🛑 Cease! Desist!
@TexasGOP @GregAbbott_TX @JohnCornyn @SenTedCruz @TXGOPCaucus @TexasHouse @CeliaIsrael @RepMcCaul @Transition46 @JoeBiden @SenKamalaHarris Sedition is a federal offense, just sayin! ⤵️
“Her comment comes as 45 personally leaned on lawmakers/ state leaders, Ward included, following his election loss to Biden last month-45 urged them to take steps that would overturn states' election results. thehill.com/homenews/state…
Nov 23, 2020 6 tweets 3 min read
Modernizing and Clarifying the Physician Self-Referral Regulations Final Rule (CMS-1720-F) cms.gov/newsroom/fact-… HHS conceded laws, are “potentially inhibiting beneficial arrangements ➡️advance transition to value-based care/ improve coordination of patient care among providers➡️ across care settings in Federal health care programs ➡️ commercial sector.” seyfarth.com/news-insights/…
Nov 22, 2020 6 tweets 2 min read
Public Hearing on Notice of Proposed Rulemaking 11/23/20 Agenda/ Public Hearing: Securing Updated and Necessary Statutory Evaluations Timely Notice of Proposed Rulemaking
November 23, 2020
10a.m. – 2 p.m. Eastern Time) Dial-in: +1-415-527-5035 (access code): 199 934 0311
Password: jB4kisMJt47 hhs.gov/sites/default/…
Sep 16, 2020 6 tweets 2 min read
CMS releases the Federal Meta-Evaluation Design for Section 1115 Substance Use Disorder (SUD) Demonstrations medicaid.gov/medicaid/downl… (CMS) released an evaluation design that explains how the Agency will conduct a meta-analysis on Medicaid section 1115 Substance Use Disorder (SUD) demonstrations, which will be complete in the spring of 2023.
Sep 11, 2020 11 tweets 2 min read
Texas HHS Vendor Drug Vendor Reminder: "Quantity Prescribed" Required for Schedule II Drugs Beginning Sept. 21 September 2, 2020

Beginning Sept. 21, 2020, VDP will require the "Quantity Prescribed" field (460–ET) on all pharmacy claims for Schedule II drugs.

CMS published a final rule on Jan. 24, 2020
Sep 1, 2020 19 tweets 4 min read
Texas HHS Vendor Drug Program (VDP) will implement a uniform opioid policy for Medicaid (both fee-for-service and managed care) and CHIP to encourage appropriate use and reduce opioid over-prescribing effective 9/1/20. #DPPRtx txvendordrug.com/about/news/202… 1) Recently, HHS Federal Register “more or less” in very “ambiguous language” advised that the Feds were passing the buck to the States, and that States were only “liable” to adhere to “minimum Federal standards” for participation in Medicaid (qualify
Jun 20, 2020 4 tweets 2 min read
CMS wants to introduce “..new Medicaid Drug Utilization Review (DUR) provisions designed to reduce opioid related fraud, misuse and abuse..” Docket Number: CMS-2482-P federalregister.gov/documents/2020… H. Changes Related to the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act
Pg 17-18
s3.amazonaws.com/public-inspect…